Skip to main content
. 2019 Oct 7;25(37):5711–5731. doi: 10.3748/wjg.v25.i37.5711

Table 4.

Results of sensitivity analysis of total laparoscopic pancreaticoduodenectomy vs open pancreaticoduodenectomy

Outcomes of interest No. of Studies Sample size
Heterogeneity
Model Overall effect size 95%CI of overall effect P-value
TLPD OPD P I2
Operative time 10 577 1064 < 0.00001 98% R WMD = 74.66 43.71, 105.62 < 0.00001
EBL 9 547 1034 < 0.00001 95% R WMD = -280.46 -347.73, -213.19 < 0.00001
Transfusion rate 10 573 1071 0.15 32% F OR = 0.45 0.35, 0.58 < 0.00001
Overall morbidity 9 381 607 0.31 15% F OR = 0.88 0.65, 1.18 0.38
Major morbidity 15 829 1414 0.49 0 F OR = 0.75 0.59, 0.96 0.02
POPF 15 617 1003 0.61 0 F OR = 0.82 0.64, 1.05 0.11
POPF (grade B/C) 17 877 1531 0.89 0 F OR = 0.86 0.66, 1.11 0.24
DGE 10 523 801 0.93 0 F OR = 0.93 0.64, 1.34 0.69
DGE (grade B/C) 7 479 994 0.60 0 F OR = 0.63 0.45, 0.88 0.006
PPH 11 434 737 0.84 0 F OR = 1.48 0.93, 2.36 0.10
PPH (grade B/C) 7 454 966 0.91 0 F OR = 1.02 0.65, 1.60 0.95
Bile leak 7 232 232 0.93 0 F OR = 1.00 0.45, 2.25 0.99
Gastroente-ric anastomosis fistula 3 136 133 0.54 0 F OR = 0.49 0.09, 2.73 0.42
Wound infection 9 332 697 0.46 0 F OR = 0.57 0.39, 0.84 0.005
Intra-abdominal abscess 5 175 340 0.23 29% F OR = 0.74 0.39, 1.38 0.34
Bowel obstruction 2 73 73 0.33 0 F OR = 1.00 0.14, 7.31 1.00
Fluid collection 2 77 77 0.96 0 F OR = 0.63 0.21, 1.89 0.41
Pneumonia 10 463 880 0.99 0 F OR = 0.79 0.54, 1.15 0.21
Cardiac event 4 239 648 0.48 0 F OR = 1.11 0.75, 1.62 0.61
Reoperation 12 544 990 0.46 0 F OR = 0.76 0.48, 1.21 0.25
ICU admission 2 171 283 0.40 0 F OR = 0.90 0.53, 1.54 0.71
ICU stay 2 65 227 0.62 0 F WMD = -2.08 -2.88, -1.29 < 0.00001
Diet start time 3 175 284 <0.0001 90% R WMD = -1.75 -3.38, -0.12 0.04
LOS 8 332 500 0.004 67% R WMD = -3.69 -4.90, -2.48 < 0.00001
Discharge to a new facility 3 218 490 0.60 0 F OR = 0.50 0.28, 0.87 0.01
30-d readmission 6 340 508 0.77 0 F OR = 1.04 0.68, 1.59 0.86
90-d readmission 4 136 279 0.70 0 F OR = 1.07 0.62, 1.84 0.81
30-d mortality 12 527 1271 0.76 0 F OR = 1.26 0.59, 2.68 0.55
90-d mortality 9 312 661 0.96 0 F OR = 0.60 0.31, 1.17 0.14
Time to adjuvant chemothe-rapy 1 39 141 NA NA F WMD = -5.50 -12.71, 1.71 0.14
Tumor size 9 430 745 0.0002 73% R WMD = -0.36 -0.63, -0.09 0.008
RLNs 10 388 925 < 0.00001 79% R WMD = 1.28 0.29, 2.27 0.01
R0 rate 16 605 1535 0.87 0 F OR = 1.44 1.07, 1.94 0.02
OS of PDAC
1-yr OS 2 65 427 0.49 0 F OR = 0.65 0.37, 1.13 0.12
2-yr OS 2 65 427 0.74 0 F OR = 0.54 0.27, 1.07 0.08
3-yr OS 2 65 427 0.37 0 F OR = 0.98 0.46, 2.10 0.96
4-yr OS 2 65 427 0.82 0 F OR = 1.04 0.43, 2.52 0.93
5-yr OS 2 65 427 0.27 17% F OR = 0.65 0.19, 2.23 0.49
OS of periampullary adenocarcinoma patients
1-yr OS 2 23 234 0.004 88% R OR = 0.85 0.01, 107.31 0.95
3-yr OS 2 23 234 0.01 84% R OR = 0.90 0.01, 86.00 0.96
5-yr OS 2 23 234 0.26 20% F OR = 1.57 0.43, 5.73 0.49

NA: Not applicable; EBL: Estimated blood loss; Major morbidity: Clavien-Dindo classification ≥ III; RLNs: Retrieved lymph nodes; POPF: Postoperative pancreatic fistula; DGE: Delayed gastric emptying; PPH: Postpancreatectomy hemorrhage; LOS: Length of hospital stay; ICU: Intensive care unit; RFS: Recurrence-free survival; OS: Overall survival; PDAC: Pancreatic ductal adenocarcinoma; WMD: Weighted mean difference; OR: Odds ratio; CI: Confidence interval; F: Fixed-effects model; R: Random-effects model; TLPD: Total laparoscopic pancreaticoduodenectomy; OPD: Open pancreaticoduodenectomy.